altona Diagnostics GmbH
http://www.altona-diagnostics.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From altona Diagnostics GmbH
Finance Watch: Venture Capital Drives Record-Breaking Year For Cell And Gene Therapies
Private Company Edition: Recent VC financings across biopharma sectors include three major mega-rounds as Generate Biomedicines bringing in $370m, followed by $250m for Acelyrin and $125m for Chroma Medicine. Also, Treadwell raised a $91m series B and Ncardia brought in $60m-plus.
More German Companies Get To Work On COVID-19 Diagnostic Test Development
Another three in vitro diagnostics companies in Germany are working on tests for the early detection of COVID-19, with confirmed infections reaching 89,000 globally by 2 March.
FDA Clears Another Zika Assay, Luminex's xMap
The xMap Multiflex Zika RNA Assay is a molecular diagnostic that is designed to detect the Zika virus in human serum, urine or plasma.
Manufacturer Doesn’t Expect Zika Blood-Screening Test Shortage
US FDA has asked Miami-area blood banks to close until they can screen all blood supplies for the Zika virus in the wake of the first known cases transmitted by mosquitos within the US. A manufacturer of the only test currently available for blood-bank use does not expect shortages, despite the increased demand.
Company Information
- Industry
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice